Nuvation Bio Inc.
- Stock
- Ticker NUVB
- ISIN US67080N1019
- NYSE
Performance, volatility and drawdowns of Nuvation Bio Inc. since 08/2020, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $4,144. Global equities (VT): $14,653.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −93.4% in 10/2023, measured from the peak in 03/2021. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 5.7 | 3.1 | 4.8 | 13 | 42 | 83 | 32 | 45 |
| Gross profit | 1.5 | 1.0 | 2.3 | 9.8 | – | – | – | – |
| Operating income | -54 | -59 | -64 | -56 | -34 | 3.9 | -51 | -42 |
| EBITDA | -54 | -59 | -63 | -56 | -33 | 4.4 | -51 | -42 |
| Net income | -49 | -53 | -59 | -56 | -37 | 5.4 | -63 | -42 |
| Earnings per share | 0.00 | -0.16 | -0.17 | -0.16 | -0.11 | 0.01 | -0.18 | -0.12 |
| Balance sheet | ||||||||
| Total assets | 541 | 492 | 647 | 602 | 595 | 610 | 745 | 778 |
| Liabilities | 77 | 73 | 274 | 276 | 289 | 291 | 491 | 550 |
| Equity | 464 | 419 | 373 | 326 | 306 | 320 | 254 | 228 |
| Cash | 36 | 48 | 248 | 99 | 164 | 125 | 259 | 154 |
| Long-term debt | – | – | 47 | 47 | 47 | 47 | 243 | 279 |
| Cash flow | ||||||||
| Operating cash flow | -46 | -43 | -48 | -53 | -30 | 5.1 | -43 | -39 |
| Free cash flow | -46 | -43 | -48 | -53 | -30 | 5.1 | -43 | -39 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +236.8%, weakest 2022 at −77.4%. 2 of 5 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 4 Nov 2026 | −$0.12 |
| 6 Aug 2026 | −$0.18 |
| 4 May 2026 | $0.01 |
| 2 Mar 2026 | −$0.11 |
| 3 Nov 2025 | −$0.16 |
| 7 Aug 2025 | −$0.17 |
| 7 May 2025 | −$0.16 |
| 6 Mar 2025 | $0.00 |
| 6 Nov 2024 | −$0.15 |
| 5 Aug 2024 | −$1.89 |
| 14 May 2024 | −$0.07 |
| 29 Feb 2024 | −$0.07 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €1.2bn
- Market cap in trading currency
- $1.34bn
- Enterprise value
- $964m
- P/E
- –
- P/S
- 6.65
- P/B
- 5.88
- EV/Sales
- 4.78
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -7.9%
Results (last four quarters)
- Revenue
- $202m
- Gross profit
- –
- EBITDA
- −$121m
- Net income
- −$136m
- Earnings per share
- −$0.40
- Revenue per share
- $0.57
- Revenue growth
- +242.6%
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- -61.2%
- Net margin
- -67.4%
- Return on equity
- -49.1%
- Return on assets
- -17.5%
Balance sheet and cash flow
- Cash
- $663m
- Cash per share
- $1.88
- Financial debt
- $285m
- Debt/equity %
- 125
- Current ratio
- 7.45
- Book value per share
- $0.65
- Operating cash flow
- −$106m
- Free cash flow
- −$106m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 353m
- Volume
- 6.85m
- Avg. volume 3 months
- 5.22m
- Relative volume
- 1.3
Price and technicals
- Price
- $3.80
- 1 day
- −0.3%
- 52-week high
- $9.54
- 52-week low
- $3.78
- Distance to 52-week high
- −60.2%
- Distance to 52-week low
- +0.5%
- Distance to 50-day line
- −21.9%
- Distance to 200-day line
- −28.0%
- RSI (14)
- 31
- Volatility 1M
- 58.1%
Performance
- 1 week
- −4.8%
- 1 month
- −19.1%
- 3 months
- −43.8%
- 6 months
- −19.5%
- YTD
- −57.6%
- 1 year
- −46.9%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has NUVB performed since 08/2020?
$10,000 grew to $3,800 by 20 Nov 2026, which is −14.4% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is NUVB?
Volatility was 74.6% per year, measured on monthly returns. The largest decline from a peak was −93.4%, with the low in 10/2023.
How does NUVB compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.2% per year at 15.1% volatility, NUVB returned −14.4% at 74.6%. The correlation of monthly returns was 0.33; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.